Clinical trial
Probiotic Intervention for Microbiome Modifications and Consequential Clinical Improvements in Children With Fragile X Syndrome: Pilot Study
NCT06279858 is registered in ClinicalTrials.gov with Specila hospital for cerebral palsy and developmental neurology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Probiotic Intervention for Microbiome Modifications and Consequential Clinical Improvements in Children With Fragile X Syndrome: Pilot Study
- Lead sponsor
- Specila hospital for cerebral palsy and developmental neurology
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 1, 2024
- Completion date
- December 31, 2024
- Enrollment
- 15 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.